BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16951288)

  • 1. Simplified method for determining the radiochemical purity of 99mTc-MAG3.
    Seetharaman S; Ballinger JR; Sosabowski MH
    J Nucl Med Technol; 2006 Sep; 34(3):179-83. PubMed ID: 16951288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality control of instant kit 99mTc-mercapto acetyl triglycine with inter- and intra-operator measurements.
    Bozkurt MF; Kiratli PO; Konyali D; Metin F
    Hell J Nucl Med; 2009; 12(1):59-62. PubMed ID: 19330186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of solvent flow rate in mini-column testing of 99mTc-mertiatide.
    Ponto JA
    J Nucl Med Technol; 2005 Dec; 33(4):232-3. PubMed ID: 16322124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of 99mTc-MAG3: radiochemical purity is affected by the residence time of sodium chloride injection in a three-part syringe.
    Waight CC; Beattie LA; O'Brien LM; Millar AM
    Nucl Med Commun; 2006 Feb; 27(2):197-200. PubMed ID: 16404235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transferability of a two-strip method for the quality control of technetium-99m mercaptoacetyltriglycine ([
    Tessaire T; De Neef L; Cailly T; Peyronnet D; Vigne J
    Eur J Hosp Pharm; 2023 May; 30(3):167-171. PubMed ID: 34285112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple two-strip method to determine the radiochemical purity of technetium-99m mercaptoacetyltriglycine.
    Chen F; Decristoforo C; Rohrbacher B; Riccabona G
    Eur J Nucl Med; 1993 Apr; 20(4):334-8. PubMed ID: 8491226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of SepPak and high-performance liquid chromatography as techniques for measuring the radiochemical purity of 99mTc-MAG3.
    Millar AM; Hesslewood SR
    Nucl Med Commun; 2004 Oct; 25(10):1049-51. PubMed ID: 15381873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, radiochemical purity control and stability of 99mTc-mertiatide (Mag-3).
    van Hemert FJ; van Lenthe H; Schimmel KJ; van Eck-Smit BL
    Ann Nucl Med; 2005 Jun; 19(4):345-9. PubMed ID: 16097648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 99Tc(m)-MAG3: problems with radiochemical purity testing.
    Ensing GJ; Knight HH
    Nucl Med Commun; 2001 Jan; 22(1):114-5. PubMed ID: 11233545
    [No Abstract]   [Full Text] [Related]  

  • 10. A better method of quality control for 99mTc-tetrofosmin.
    Hammes R; Joas LA; Kirschling TE; Ledford JR; Knox TL; Nybo MR; Sterzinger JJ
    J Nucl Med Technol; 2004 Jun; 32(2):72-8. PubMed ID: 15175403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing different storage conditions for (99m)Tc-MAG3 kit: can hot fractioning reduce the cost per unit dose?
    Kiratli PO; Salanci BV
    J Nucl Med Technol; 2003 Jun; 31(2):74-5. PubMed ID: 12777456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An alternative method to determine the radiochemical purity of the 99mTC-tetrofosmine preparations].
    Gómez JL; Vega F; Peñafiel A; Daumal J; Peña C; Montsech L; Mata F
    Rev Esp Med Nucl; 1999; 18(2):94-8. PubMed ID: 10352321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of 99Tcm-MAG3: no confirmation that sodium chloride injections from plastic containers affect radiochemical purity.
    Millar AM; O'Brien LM
    Nucl Med Commun; 1998 May; 19(5):475-7. PubMed ID: 9853337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identity confirmation of 99mTc-MAG3, 99mTc-sestamibi and 99mTc-ECD using radio-LC-MS.
    Verduyckt T; Kieffer D; Huyghe D; Cleynhens B; Verbeke K; Verbruggen A; Bormans G
    J Pharm Biomed Anal; 2003 Aug; 32(4-5):669-78. PubMed ID: 12899957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid determination of the radiochemical purity of 99mTc-antimony trisulfide colloid prepared by standard and alternative heating methods.
    Smyth DR
    J Nucl Med Technol; 2006 Sep; 34(3):174-8. PubMed ID: 16951287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the hepatobiliary excretion of technetium-99m-MAG3 and reconstitution factors affecting radiochemical purity.
    Shattuck LA; Eshima D; Taylor AT; Anderson TL; Graham DL; Latino FA; Payne SE
    J Nucl Med; 1994 Feb; 35(2):349-55. PubMed ID: 8295009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods for MAG3 conjugation and 99mTc radiolabeling of biomolecules.
    Wang Y; Liu G; Hnatowich DJ
    Nat Protoc; 2006; 1(3):1477-80. PubMed ID: 17406438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative quality control for technetium-99m IDA complexes.
    Billinghurst MW; Eckert K; Mang'era K
    Appl Radiat Isot; 2004 Dec; 61(6):1151-5. PubMed ID: 15388103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid chromatographic method for quality control of technetium-99m-bicisate.
    Amin KC; Saha GB; Go RT
    J Nucl Med Technol; 1997 Mar; 25(1):49-51. PubMed ID: 9239604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of alternative methods of preparing 99mTc-MAG3.
    Seetharaman S; Sosabowski MH; Ballinger JR
    Appl Radiat Isot; 2007 Nov; 65(11):1240-3. PubMed ID: 17434313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.